We are live on ! Find out more
GIP

Granite Investment Partners Portfolio holdings

AUM $1.95B
1-Year Est. Return 49.89%
This Fund
S&P 500
This Quarter Est. Return
+18.54%
1 Year Est. Return
+49.89%
3 Year Est. Return
+130.82%
5 Year Est. Return
+170.12%
10 Year Est. Return
+1,227.59%
AUM
$1.76B
AUM Growth
+$395M
Cap. Flow
+$177M
Cap. Flow %
10.03%
Top 10 Hldgs %
15.75%
Holding
384
New
50
Increased
209
Reduced
59
Closed
31

Top Buys

Rank Stock Value
1
RMAX icon
RE/MAX Holdings
RMAX
+$15.2M
2
HSKA
Heska Corp
HSKA
+$14.7M
3
AERI
Aerie Pharmaceuticals
AERI
+$12.4M
4
CMO
Capstead Mortgage Corp.
CMO
+$11.8M
5
LPSN icon
LivePerson
LPSN
+$11.7M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$18.5M
2
PAHC icon
Phibro Animal Health
PAHC
+$13.5M
3
TRHC
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
+$13.4M
4
MB
MINDBODY, Inc. Class A Common Stock
MB
+$12.2M
5
EVH icon
Evolent Health
EVH
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 18.67%
2 Healthcare 17.58%
3 Industrials 15.68%
4 Financials 9.68%
5 Consumer Discretionary 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KSU
301
DELISTED
Kansas City Southern
KSU
$482K 0.03%
4,160
– –
SPLK
302
DELISTED
Splunk Inc
SPLK
$471K 0.03%
+3,777
New +$471K
MRUS
303
DELISTED
Merus
MRUS
$468K 0.03%
+31,645
New +$405K
HYT icon
304
BlackRock Corporate High Yield Fund
HYT
$1.37B
$451K 0.03%
43,955
+589
+1% +$5.91K
CELG
305
DELISTED
Celgene Corp
CELG
$449K 0.03%
4,758
+38
+0.8% +$3.32K
BEL
306
DELISTED
Belmond Ltd.
BEL
$448K 0.03%
17,958
– –
PVLA
307
Palvella Therapeutics
PVLA
$2.27B
$443K 0.03%
+1,654
New +$393K
ZYME icon
308
Zymeworks
ZYME
$1.67B
$441K 0.03%
27,277
+12,750
+88% +$198K
KIN
309
DELISTED
Kindred Biosciences, Inc.
KIN
$436K 0.02%
47,505
+32,649
+220% +$332K
FPRX
310
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$435K 0.02%
32,442
+15,164
+88% +$173K
ACU icon
311
Acme United Corp
ACU
$215M
$389K 0.02%
24,303
+11,359
+88% +$186K
BP icon
312
BP
BP
$107B
$383K 0.02%
8,910
-130
-1% -$5.33K
CBUS icon
313
Cibus
CBUS
$138M
$383K 0.02%
436
+204
+88% +$145K
GOLD
314
Gold.com Inc
GOLD
$1.26B
$379K 0.02%
+63,578
New +$398K
POLA icon
315
Polar Power
POLA
$6.86M
$365K 0.02%
+11,560
New +$398K
DSL
316
DoubleLine Income Solutions Fund
DSL
$1.24B
$364K 0.02%
18,261
+406
+2% +$7.86K
HCA icon
317
HCA Healthcare
HCA
$89.5B
$358K 0.02%
+2,748
New +$369K
PMD
318
DELISTED
Psychemedics Corporation
PMD
$356K 0.02%
25,382
+103
+0.4% +$1.77K
OPNT
319
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$356K 0.02%
+27,143
New +$396K
RIGL icon
320
Rigel Pharmaceuticals
RIGL
$750M
$348K 0.02%
13,544
+6,333
+88% +$145K
APT icon
321
Alpha Pro Tech
APT
$53.1M
$340K 0.02%
94,392
+44,141
+88% +$173K
RELL icon
322
Richardson Electronics
RELL
$304M
$332K 0.02%
+48,984
New +$363K
IWM icon
323
iShares Russell 2000 ETF
IWM
$83B
$325K 0.02%
2,052
-123,299
-98% -$18.5M
KO icon
324
Coca-Cola
KO
$375B
$321K 0.02%
6,847
+10
+0.1% +$468
YUM icon
325
Yum! Brands
YUM
$41.1B
$319K 0.02%
3,200
– –
11 12
13
14 15

Similar funds

FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return
OCM
Osterweis Capital Management San Francisco, California $1.94B AUM 20.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Granite Investment Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Granite Investment Partners held 384 positions worth $1.76B, up 29% from $1.37B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Granite Investment Partners deployed $177M of net new capital in Q1 2019, opening 50 new positions and adding to 209 existing holdings. Its largest new stake was RE/MAX Holdings: 396,215 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $18.5M trimmed.

  • Granite Investment Partners's largest Q1 2019 buy was RE/MAX Holdings: 396,215 shares worth $15.3M.
  • Granite Investment Partners added most to Carpenter Technology in Q1 2019, an estimated $8.37M increase.
  • Granite Investment Partners's biggest Q1 2019 reduction was iShares Russell 2000 ETF, cutting an estimated $18.5M.
  • Granite Investment Partners fully exited Phibro Animal Health in Q1 2019, selling an estimated $13.5M.
  • Granite Investment Partners's ten largest holdings make up 16% of its $1.76B portfolio in Q1 2019.
  • Granite Investment Partners opened 50 new positions and closed 31 in Q1 2019.
  • Granite Investment Partners's portfolio value rose 29% quarter-over-quarter to $1.76B.

Based on Granite Investment Partners's 13F filing for Q1 2019, filed 13 May 2019.